Recent Updates
Recently added Catalysts

Clinical Reminder

Phase 3

Cardiomyopathies | Unknown | Cardiovascular |Medtronic plc.|Trials Updated: May 19, 2021

Clinical Reminder development status

Highest phase Phase 3
Registered trials 1 across 1 sponsor since Oct 2001

Success Probability

Subscribe to view

Market & Valuation

Subscribe to view

Trial Design

RandomizedNO_TREATMENT_CONTROLLED
Total Trials1
Total Enrollment89

FDA Designations

No designations recorded

Clinical Reminder clinical trials

Clinical Reminder · 1 trial · 1 indication

Phase 3 1
NCT01217827Implantable Cardioverter-Defibrillator Use in the VA SystemCardiomyopathies
COMPLETED89 Analytics
PHASE3COMPLETED
Implantable Cardioverter-Defibrillator Use in the VA System
CardiomyopathiesUnlock trial analytics

Study Endpoints

Primary Endpoints

Referral for Implantable Cardioverter Defibrillator
6 months

Referral of the patient to electrophysiology clinic for evaluation for cardioverter defibrillator implantation.

Unlock Study Endpoints

Study Design & Arms

AllocationRANDOMIZED
MaskingSINGLE
ModelPARALLEL
PurposeHEALTH_SERVICES_RESEARCH

Treatment Arms

ArmTypeDescription
Clinical ReminderEXPERIMENTALReminder of potential candidacy for an implantable cardioverter defibrillator. The reminder is placed in the medical record with copy to the primary provider and any cardiologist managing the patient.
ControlNO_INTERVENTIONThis group does not receive an intervention.

Interventions

NameTypeDescription
Clinical ReminderBEHAVIORAL -
Unlock Study Design Details

Eligibility Criteria

Age Range18 Years to N/A
SexALL
Healthy VolunteersNo
Study Sites2

Inclusion Criteria:Meeting published criteria for receipt of an implantable cardioverter defibrillator Exclusion Criteria:provider is not affiliated with the VA health care system

Countries:United States
Unlock Eligibility Criteria